The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
Andreas Günther(Cardio-Pulmonary Institute), Bruno Crestani(Inserm), Werner Seeger(Justus-Liebig-Universität Gießen), Bettina Paul(Goethe University Frankfurt), Walter Klepetko(Medical University of Vienna), Ekaterina Krauss(European Central Bank), Martina Vašáková(Charles University), Jasmin Wagner(European Central Bank), Fotios Drakopanagiotakis(Democritus University of Thrace), Silke Tello(Justus-Liebig-Universität Gießen), Olga Maurer(European Central Bank), Philippe Bonniaud(Inserm), Veronika Müller(Semmelweis University), Ulrich Costabel(Ruhrlandklinik), Athol U. Wells(St Thomas' Hospital), Alberto Pesci(University of Milano-Bicocca), Matteo Sofia(European Central Bank), S Heinemann(Justus-Liebig-Universität Gießen), Stefan Kühn(European Central Bank), María Asunción Nieto Barbero(European Central Bank), Carlo Vancheri(University of Catania)
Cited by 263
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k